Physicians’ Preferences for Communication of Pharmacist-Provided Medication Therapy Management in Community Pharmacy

Abstract

Objectives:

(1) To identify physicians’ preferences in regard to pharmacist-provided medication therapy management (MTM) communication in the community pharmacy setting; (2) to identify physicians’ perceived barriers to communicating with a pharmacist regarding MTM; and (3) to determine whether Missouri physicians feel MTM is beneficial for their patients.

Methods:

A cross-sectional prospective survey study of 2021 family and general practice physicians registered with MO HealthNet, Missouri’s Medicaid program.

Results:

The majority (52.8%) of physicians preferred MTM data to be communicated via fax. Most physicians who provided care to patients in long-term care (LTC) facilities (81.0%) preferred to be contacted at their practice location as opposed to the LTC facility. The greatest barriers to communication were lack of time and inefficient communication practices. Improved/enhanced communication was the most common suggestion for improvement in the MTM process. Approximately 67% of respondents reported MTM as beneficial or somewhat beneficial for their patients.

Conclusions:

Survey respondents saw value in the MTM services offered by pharmacists. However, pharmacists should use the identified preferences and barriers to improve their currently utilized communication practices in hopes of increasing acceptance of recommendations. Ultimately, this may assist MTM providers in working collaboratively with patients’ physicians.

Keywords

medication therapy management community pharmacy communication physician preferences barriers

Get full access to this article

View all access options for this article.

References

Institute of Medicine. Preventing medication errors; 2006. Web site. https://www.iom.edu/~/media/Files/Report%20Files/2006/Preventing-Medication-Errors-Quality-Chasm-Series/medicationerrorsnew.pdf. Accessed May 11, 2015.

Ernst

Grizzle

. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001;41(2):192–199.

Sarkar

Lopez

Maselli

. Adverse drug events in U.S. adult ambulatory medical care. Health Serv Res. 2011;46(5):1517–1533.

Gandhi

Weingart

Borus

. Adverse drug events in ambulatory care. N Engl J Med. 2003;348(16):1556–1564.

Gurwitz

Field

Harrold

. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289(9):1107–1016.

World Health Organization. Adherence to long-term therapies: evidence for action; 2003. Web site. http://www.who.int/chp/knowledge/publications/adherence_introduction.pdf?ua=1. Accessed May 11, 2015.

Osterberg

Blaschke

. Adherence to medication. N Engl J Med. 2005;353(5):487–497.

Perlroth

Marrufo

Montesinos

. Medication therapy management in chronically ill populations: final report; 2013. Web site. http://innovation.cms.gov/Files/reports/MTM_Final_Report.pdf. Accessed May 11, 2015.

Centers for Medicare and Medicaid Services. Medicare program: Medicare prescription drug benefit; 2005. Web site. http://www.gpo.gov/fdsys/pkg/FR-2005-01-28/pdf/05-1321.pdf. Accessed May 11, 2015.

10.

Burns

. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc. 2008;48(3):341–353.

11.

Perera

Guy

Sweaney

. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP). J Manag Care Pharm. 2011;17(5):345–354.

12.

Lauffenburger

Burkhart

. Design of a medication therapy management program for Medicare beneficiaries: qualitative findings from patients and physicians. Am J Geriatr Pharmacother. 2012;10(2):129–137.

13.

Padiyara

Rabi

. Physician perceptions of pharmacist provision of outpatient medication therapy management services. J Am Pharm Assoc. 2006;46(6):660–663.

14.

Alkhateeb

Unni

Latif

. Physician attitudes toward collaborative agreements with pharmacists and their expectations of community pharmacists’ responsibilities in West Virginia. J Am Pharm Assoc. 2009;49(6):797–800.

15.

Alkhateeb

Clauson

McCafferty

. Physician attitudes toward pharmacist provision of medication therapy management services. Pharm World Sci. 2009;31(4):487–493.

16.

McGrath

Snyder

Dueñas

. Physician perceptions of pharmacist-provided medication therapy management: qualitative analysis. J Am Pharm Assoc. 2010;50(1):67–71.

17.

Oladapo

Rascati

. Review of survey articles regarding medication therapy management (MTM) services/programs in the United States. J Pharm Pract. 2012;25(4):457–470.

18.

McDonough

Bennett

. Improving communication skills of pharmacy students through effective precepting. Am J Pharm Educ. 2006;70(3):58.

19.

Field

Cadoret

Brown

. Surveying physicians, do components of the “Total Design Approach” to optimizing survey response rates apply to physicians? Med Care. 2002;40(7):596–605.